Live Feeds

Source map — Silicon Valley's longevity drug obsession is facing its first real reality check

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
TechSpot news 60%
Deseret News news 60%
Fast Company news 60%
VailDaily.com news 60%
www.thecooldown.com news 50%
summabase.com news 50%
longevitynext.com news 50%
thebeyondtomorrowpodcast.wordpress.com news 50%
www.rapamycin.news news 50%
pharmaphorum.com news 50%
www.modernpeptidescience.com news 50%